APA (7th ed.) Citation

Yaowaluk T, Senanarong V, Limwongse C, Boonprasert R, & Kijsanayotin P. (2019). Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia. Dove Medical Press.

Chicago Style (17th ed.) Citation

Yaowaluk T, Senanarong V, Limwongse C, Boonprasert R, and Kijsanayotin P. Influence of CYP2D6, CYP3A5, ABCB1, APOE Polymorphisms and Nongenetic Factors on Donepezil Treatment in Patients with Alzheimer’s Disease and Vascular Dementia. Dove Medical Press, 2019.

MLA (9th ed.) Citation

Yaowaluk T, et al. Influence of CYP2D6, CYP3A5, ABCB1, APOE Polymorphisms and Nongenetic Factors on Donepezil Treatment in Patients with Alzheimer’s Disease and Vascular Dementia. Dove Medical Press, 2019.